{"id":"https://openalex.org/W4392526554","doi":"https://doi.org/10.53555/jptcp.v29i04.4828","title":"IN SILICO DRUG DESIGNING AND DOCKING STUDY FOR NOVEL ANTIHYPERTENSIVE HYBRIDS","display_name":"IN SILICO DRUG DESIGNING AND DOCKING STUDY FOR NOVEL ANTIHYPERTENSIVE HYBRIDS","publication_year":2022,"publication_date":"2022-04-10","ids":{"openalex":"https://openalex.org/W4392526554","doi":"https://doi.org/10.53555/jptcp.v29i04.4828"},"language":"en","primary_location":{"id":"doi:10.53555/jptcp.v29i04.4828","doi":"https://doi.org/10.53555/jptcp.v29i04.4828","is_oa":true,"landing_page_url":"https://doi.org/10.53555/jptcp.v29i04.4828","pdf_url":"https://www.jptcp.com/index.php/jptcp/article/download/4828/4673","source":{"id":"https://openalex.org/S4210224141","display_name":"Journal of Population Therapeutics and Clinical Pharmacology","issn_l":"1710-6222","issn":["1710-6222","1198-581X","2561-8741"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310318016","host_organization_name":"Codon Publications","host_organization_lineage":["https://openalex.org/P4310318016"],"host_organization_lineage_names":["Codon Publications"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Population Therapeutics and Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.jptcp.com/index.php/jptcp/article/download/4828/4673","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5104267812","display_name":"Ashwini A. Bhosale","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Ashwini A. Bhosale","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, Sinhgad Technical Education Society, Sinhgad College of Pharmacy, Vadgaon(Bk), Pune 411041, Maharashtra, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, Sinhgad Technical Education Society, Sinhgad College of Pharmacy, Vadgaon(Bk), Pune 411041, Maharashtra, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084654563","display_name":"Ganesh Sakharam Andhale","orcid":"https://orcid.org/0000-0003-2977-1282","observed_orcids":["https://orcid.org/0000-0003-2977-1282"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ganesh S. Andhale","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, Alard College of Pharmacy, Marunje, Hinjwadi, Pune-411028, Maharashtra, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, Alard College of Pharmacy, Marunje, Hinjwadi, Pune-411028, Maharashtra, India","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051874929","display_name":"Rajesh B. Patil","orcid":"https://orcid.org/0000-0003-2986-9546","observed_orcids":["https://orcid.org/0000-0003-2986-9546"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rajesh B. Patil","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, Alard College of Pharmacy, Marunje, Hinjwadi, Pune-411028, Maharashtra, India","Department of Pharmaceutical Chemistry, Sinhgad Technical Education Society, Sinhgad College of Pharmacy, Vadgaon(Bk), Pune 411041, Maharashtra, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, Alard College of Pharmacy, Marunje, Hinjwadi, Pune-411028, Maharashtra, India","institution_ids":[]},{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, Sinhgad Technical Education Society, Sinhgad College of Pharmacy, Vadgaon(Bk), Pune 411041, Maharashtra, India","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5104267812"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9794999957084656,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9794999957084656,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.006099999882280827,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.0052999998442828655,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antihypertensive-drugs","display_name":"antihypertensive drugs","score":0.8999999761581421},{"id":"https://openalex.org/keywords/hybrid-drug-design","display_name":"hybrid drug design","score":0.6420000195503235},{"id":"https://openalex.org/keywords/nitric-oxide-donors","display_name":"nitric oxide donors","score":0.6919999718666077},{"id":"https://openalex.org/keywords/thiazolidin-4-ones","display_name":"thiazolidin-4-ones","score":0.878000020980835},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.8149999976158142},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.5189999938011169},{"id":"https://openalex.org/keywords/amlodipine","display_name":"amlodipine","score":0.7549999952316284},{"id":"https://openalex.org/keywords/vasodilator-activity","display_name":"vasodilator activity","score":0.7440000176429749},{"id":"https://openalex.org/keywords/antiarrhythmic-activity","display_name":"antiarrhythmic activity","score":0.9010000228881836},{"id":"https://openalex.org/keywords/binding-affinity","display_name":"binding affinity","score":0.47200000286102295}],"concepts":[{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.8562597036361694},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.6830153465270996},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.5806179642677307},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.529628574848175},{"id":"https://openalex.org/C2780192228","wikidata":"https://www.wikidata.org/wiki/Q575890","display_name":"Antihypertensive drug","level":3,"score":0.4828691780567169},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3988787829875946},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2852737307548523},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.22580832242965698},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2241269052028656},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09141805768013},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.08291289210319519},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.07924410700798035},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.53555/jptcp.v29i04.4828","doi":"https://doi.org/10.53555/jptcp.v29i04.4828","is_oa":true,"landing_page_url":"https://doi.org/10.53555/jptcp.v29i04.4828","pdf_url":"https://www.jptcp.com/index.php/jptcp/article/download/4828/4673","source":{"id":"https://openalex.org/S4210224141","display_name":"Journal of Population Therapeutics and Clinical Pharmacology","issn_l":"1710-6222","issn":["1710-6222","1198-581X","2561-8741"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310318016","host_organization_name":"Codon Publications","host_organization_lineage":["https://openalex.org/P4310318016"],"host_organization_lineage_names":["Codon Publications"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Population Therapeutics and Clinical Pharmacology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.53555/jptcp.v29i04.4828","doi":"https://doi.org/10.53555/jptcp.v29i04.4828","is_oa":true,"landing_page_url":"https://doi.org/10.53555/jptcp.v29i04.4828","pdf_url":"https://www.jptcp.com/index.php/jptcp/article/download/4828/4673","source":{"id":"https://openalex.org/S4210224141","display_name":"Journal of Population Therapeutics and Clinical Pharmacology","issn_l":"1710-6222","issn":["1710-6222","1198-581X","2561-8741"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310318016","host_organization_name":"Codon Publications","host_organization_lineage":["https://openalex.org/P4310318016"],"host_organization_lineage_names":["Codon Publications"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Population Therapeutics and Clinical Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320326590","display_name":"Savitribai Phule Pune University","ror":"https://ror.org/044g6d731"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4392526554.pdf","grobid_xml":"https://content.openalex.org/works/W4392526554.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W1554460185","https://openalex.org/W1985588649","https://openalex.org/W1989852736","https://openalex.org/W1997108602","https://openalex.org/W2001840150","https://openalex.org/W2003794633","https://openalex.org/W2004587361","https://openalex.org/W2009165423","https://openalex.org/W2018317822","https://openalex.org/W2053984137","https://openalex.org/W2061637329","https://openalex.org/W2072983751","https://openalex.org/W2073279210","https://openalex.org/W2078990008","https://openalex.org/W2134967712","https://openalex.org/W2339568953","https://openalex.org/W2547695175","https://openalex.org/W2552689420","https://openalex.org/W3027875017","https://openalex.org/W3149078497","https://openalex.org/W4231036707","https://openalex.org/W4231239312","https://openalex.org/W4250876476","https://openalex.org/W4254296590","https://openalex.org/W6679215085"],"related_works":["https://openalex.org/W2989380862","https://openalex.org/W2994647636","https://openalex.org/W4411385334","https://openalex.org/W4388905578","https://openalex.org/W3110437454","https://openalex.org/W4415285443","https://openalex.org/W3204044889","https://openalex.org/W4405457843","https://openalex.org/W2947430532","https://openalex.org/W7118119079"],"abstract_inverted_index":{"This":[0],"work":[1],"aimed":[2],"to":[3,27,35,62,114],"conduct":[4],"docking":[5,65,137],"and":[6,31,77,109,120,126],"novel":[7],"antihypertensive":[8],"agents":[9],"having":[10],"three":[11],"moieties":[12,41],"of":[13,16,19,49,91,139],"different":[14],"mechanisms":[15],"action;":[17],"one":[18],"which":[20,24],"is":[21,25,33],"NO":[22],"donor,":[23],"reported":[26,34],"possess":[28,36],"vasodilator":[29],"activity":[30],"thiazolidine-4-one":[32],"antiarrhythmic":[37],"activity.":[38],"These":[39],"two":[40],"were":[42,57,71],"clubbed":[43],"through":[44],"\u03b2-blocking":[45],"moiety.":[46],"9":[47],"derivatives":[48],"general":[50],"formula":[51],"2-(4-(2-hydroxy":[52],"-3-(4-oxo-2-phenylimino)":[53],"thizolidin-3-yl)":[54],"phenyl)-2-oxoethyl":[55],"nitrate":[56],"selected.":[58],"Schrodinger":[59],"was":[60,102],"used":[61],"perform":[63],"molecular":[64],"using":[66,73,84],"Maestro":[67,74],"Glide.":[68],"All":[69],"compounds":[70],"constructed":[72],"build":[75],"panels":[76],"then":[78],"optimized":[79],"for":[80],"lower":[81],"energy":[82],"conformers":[83],"Ligprep":[85],"(Schrodinger,":[86],"LLC).":[87],"With":[88],"the":[89,95,105,131,135],"help":[90],"protein":[92,96,106],"preparation":[93],"wizards,":[94],"X-ray":[97],"crystal":[98],"structure":[99],"(PDB":[100],"ID:6M7H)":[101],"obtained":[103],"from":[104],"data":[107],"bank":[108],"made":[110],"docking-ready.":[111],"When":[112],"compared":[113],"amlodipine,":[115],"SD7,":[116],"SD3,":[117],"SD9,":[118],"SD4,":[119],"SD8":[121],"show":[122],"good":[123,127],"binding":[124],"patterns":[125],"scores.":[128],"Of":[129],"all":[130],"molecules,":[132],"SD7":[133],"has":[134],"highest":[136],"score":[138],"-9.177":[140],"kcal":[141],"mol\u22121.":[142]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-03-07T00:00:00"}